|
|
|
EuroSciCon, Cineworld: The O2 Peninsula Square London London SE10 0DX United Kingdom
Tuesday, 12 May 2015 09:00 - Thursday, 14 May 2015 17:00
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment. Presenters will include Clinicians, Academics and members of the Pharmaceutical industry and we encourage presentations from the wide spectrum of cancer research, development and healthcare professionals. This event has CPD accreditation
Who Should Attend The conference is open to academics, clinicians and industrial partners creating a stimulating environment in which to promote lively discussion, productive collaboration and innovation. This will be a paperless meeting, please print out the agenda before you come or download the pdf onto your computer or smartphone.
Pdfs of our agendas can be found at http://lifescienceevents.com/events
|
|
|
|
|
|
Organized by:
|
|
Euroscicon |
|
Invited Speakers:
|
|
Talks include:
ErbB-targeted CAR T-cell immunotherapy of cancer: a strategy to maximize the window of therapeutic opportunity. Dr John Maher, Senior Lecturer in Immunology, NIHR Biomedical Research Centre at Guy¹s and St Thomas¹ NHS Foundation, Trust and King¹s College London, Research Oncology, Division of Cancer Studies, Guy's Hospital campus, St Thomas St, London, United Kingdom
Current status of minimally invasive diagnosis and staging of lung malignancies Dr Jorge Pascual, MD, Assistant Professor, Mayo Clinic College of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Florida, USA
Overcoming Mechanisms of Therapeutic Resistance in Advanced Castration Resistant Prostate Cancer Dr Natasha Kyprianou, James F. Hardymon Chair in Urology Research, Professor of Urology, Molecular Biochemistry, Pathology and Toxicology, Combs, Rm 306, University of Kentucky College of Medicine, Lexington, KY, US
Breast Cancer, Chemo-resistance and ErbB receptors Professor Zhixiang Wang, PhD, Department of Medical Genetics, Signal Transduction Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
|
|
|
|
|
|
Deadline for Abstracts:
|
|
The Deadline for abstract submissions for oral presentation is Feb 10th 2015
|
|
|
|
|
|
Registration:
|
|
Click here to register
|
|
E-mail:
|
|
enquiries@euroscicon.com
|
|
|
|
|
|
|
|